On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …

Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.